Deciphering key parameters enhancing lentiviral vector producer cells yields: Vector components copy number and expression
Open Access
- 11 February 2025
- journal article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 33 (1) , 101431
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e a Tecnologia
This publication has 26 references indexed in Scilit:
- Progress and Perspectives in the Development of Lentiviral Vector Producer CellsBiotechnology Journal, 2020
- Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV PseudotypesMolecular Therapy - Methods & Clinical Development, 2019
- LentiPro26: novel stable cell lines for constitutive lentiviral vector productionScientific Reports, 2018
- Interactions between Retroviruses and the Host Cell GenomeMolecular Therapy - Methods & Clinical Development, 2018
- RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelopeMolecular Therapy - Methods & Clinical Development, 2016
- Universal Real-Time PCR-Based Assay for Lentiviral TitrationMolecular Biotechnology, 2014
- Quantitation of MLV-based retroviral vectors using real-time RT-PCRJournal of Virological Methods, 2004
- Exploration of critical parameters for transient retrovirus productionJournal of Biotechnology, 2003
- Continuous high-titer HIV-1 vector productionNature Biotechnology, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001